Clinical Trial Update: Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating regional citrate anticoagulation in extended hemodialysis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodialysis-related Complications
• Kidney Injury

Drugs mentioned

• Regional citrate anticoagulation

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Hemodialysis Complication, Acute Kidney Injury | Phase 3 | Status: SUSPENDED